Tatva Chintan Pharma Chem Limited

NSE TATVA.NS

Tatva Chintan Pharma Chem Limited Interest Coverage Ratio for the year ending March 31, 2024: 8.14

Tatva Chintan Pharma Chem Limited Interest Coverage Ratio is 8.14 for the year ending March 31, 2024, a 28.72% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Tatva Chintan Pharma Chem Limited Interest Coverage Ratio for the year ending March 31, 2023 was 6.32, a -75.40% change year over year.
Tatva Chintan Pharma Chem Limited Interest Coverage Ratio for the year ending March 31, 2022 was 25.70, a 57.50% change year over year.
Tatva Chintan Pharma Chem Limited Interest Coverage Ratio for the year ending March 31, 2021 was 16.32, a 18.16% change year over year.
Tatva Chintan Pharma Chem Limited Interest Coverage Ratio for the year ending March 31, 2020 was 13.81, a 45.45% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

NSE: TATVA.NS

Tatva Chintan Pharma Chem Limited

CEO	Mr. Chintan Nitinkumar Shah
IPO Date	July 29, 2021
Location	India
Headquarters	Plot No. 353
Employees	689
Sector	Materials
Industries Chemicals & Advanced Materials Petrochemicals Pharmaceuticals

Description

Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also provides quaternary compounds and quats, and bulk drugs, as well as trading of specialty chemicals. It serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. The company also exports its products to approximately 25 countries. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.

Key trends

Past 5 years